Piper Sandler's Neutral initiation is a mild contrarian call against a heavily bullish consensus, but the firm's average accuracy and the stock's modest upside to their target limit its urgency. Traders should watch the July 21 earnings for directional confirmation; the elevated short interest adds potential for a squeeze if results beat expectations.
Price Chart
Executive Summary
Piper Sandler initiated coverage on Thermo Fisher Scientific at Neutral with a $510 price target, implying a modest 5.8% upside from the current $482.04. The firm's 54% accuracy on 3,763 calls and average 3.6% return position it near the middle of analysts covering TMO. The broader consensus remains heavily bullish: 29 of 34 analysts rate the stock Buy (85%), with only 5 Holds and zero Sells. The mean price target is $602.76 (25% upside), while Piper's $510 sits just above the consensus low of $490. EPS revisions over the past 30 days are mixed—current-quarter estimates saw 12 downward revisions vs. 2 upward, but next-quarter estimates improved 14 up vs. 3 down. Insider activity is limited: one small sale in late April and two small Congressional trades (one buy, one sell). Institutional flows show a major add by Capital Research (+51.5%) and a new position from Renaissance Technologies, offset by significant trims from Wellington and Capital World. Short interest is elevated at a 62% ratio, suggesting bearish positioning. Overall, Piper's cautious initiation contrasts with the bullish street view, but given its average track record, the call carries limited catalyst weight unless earnings on July 21 surprise.
Impact Score
Consensus & Targets
Of 34 analysts covering TMO, 11 rate it Strong Buy, 18 rate Buy (total 85% Buy), 5 rate Hold, and none rate Sell or Strong Sell. The consensus is firmly bullish, with Piper Sandler's Neutral stance as a more cautious outlier.
Current price: $482.04. Consensus mean target: $602.76, median $600, high $750, low $490. Piper Sandler's $510 target implies 5.8% upside, well below the mean's 25% implied upside and just above the consensus low.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-11 | Piper Sandler | initiate | Neutral | $510.00 |
| 2026-06-03 | HSBC | downgrade | Hold | $540.00 |
| 2026-05-08 | Wells Fargo | maintain | Overweight | $615.00 |
| 2026-04-24 | Stifel | maintain | Buy | $600.00 |
| 2026-04-24 | Baird | maintain | Outperform | $639.00 |
| 2026-04-14 | Barclays | maintain | Overweight | $625.00 |
| 2026-04-06 | Evercore ISI Group | maintain | Outperform | $575.00 |
| 2026-01-30 | Citigroup | maintain | Buy | $685.00 |
| 2026-01-30 | TD Cowen | maintain | Buy | $683.00 |
| 2026-01-30 | Barclays | maintain | Overweight | $650.00 |
Over the past 30 days, TMO has seen 1 upgrade and 1 downgrade (HSBC downgraded to Hold on June 3). EPS revision trends are mixed: current quarter estimates were revised down 12 times vs. 2 up, but next-quarter estimates saw 14 upward revisions vs. 3 down. Overall, near-term estimates are softening while forward estimates are improving.
Firm Track Record — Piper Sandler
Piper Sandler accuracy: 54% on 3763 calls | avg return: 3.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Argus Research | 100% | 2/2 | 9.5% | top tier |
| Baird | 83% | 5/6 | 10.5% | top tier |
| Barclays | 80% | 8/10 | 8.5% | top tier |
| Evercore ISI Group | 71% | 5/7 | 7% | top tier |
| JP Morgan | 67% | 2/3 | 1.8% | top tier |
| HSBC | 67% | 2/3 | -0.4% | top tier |
| UBS | 60% | 3/5 | 7.9% | above average |
| Wells Fargo | 50% | 4/8 | -2.4% | below average |
| Stifel | 50% | 2/4 | -1.6% | below average |
| RBC Capital | 50% | 2/4 | -1.6% | below average |
Piper Sandler has a 54% accuracy rate on 3,763 rated stocks with an average return of 3.6%. Among firms covering TMO, the best performers are Argus Research (100% on 2 calls), Baird (83% on 6), and Barclays (80% on 10). The weakest are Morgan Stanley (20% on 5) and Citigroup (25% on 4). Piper's accuracy is average relative to this peer set.
Earnings Estimates
Next earnings: Jul 21, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $5.72 | $5.68 — $5.75 | $11.7B | ↑0 ↓0 |
| +1y | $27.26 | $26.25 — $29.07 | $50.3B | ↑1 ↓0 |
| +1q | $6.37 | $6.09 — $6.60 | $12.0B | ↑1 ↓0 |
| 0y | $24.86 | $24.63 — $25.03 | $47.8B | ↑1 ↓0 |
Cross-Platform Signals
Insider activity: one sell of $185k by an executive on April 27 (not a strong signal). Congressional trades: one buy (Rep. Khanna, $15k-$50k) and one sell (Rep. Evans, $1k-$15k). Institutional flows: major add by Capital Research Global (+51.5%) and new position by Renaissance Technologies, but significant trims by Capital World (-39.6%) and Wellington (-57.4%). Short interest stands at 893,621 shares with a 62% ratio (days to cover), indicating elevated bearish sentiment. These signals are mixed and do not strongly converge with Piper's cautious initiation.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Insider Cluster | $600.50 $675.05 | ▲ +12.41% | ▲ +12.30% | $650.08 (+8.26%) |
Aug 26, 2026 5w ago | Insider Cluster | $630.70 $666.33 | ▲ +5.65% | ▲ +5.75% | $650.08 (+3.07%) |
Aug 24, 2026 5w ago | Insider Cluster | $628.74 $658.52 | ▲ +4.74% | ▲ +3.42% | $650.08 (+3.39%) |
Aug 18, 2026 6w ago | Court Ruling | $589.04 $648.43 | ▲ +10.08% | ▲ +11.39% | $650.08 (+10.36%) |
Aug 13, 2026 7w ago | Insider Cluster | $588.29 $613.62 | ▲ +4.31% | ▲ +6.30% | $650.08 (+10.50%) |
Aug 10, 2026 7w ago | Insider Cluster | $605.00 $605.69 | ▲ +0.11% | ▲ +1.17% | $650.08 (+7.45%) |
Aug 7, 2026 8w ago | Insider Cluster | $594.00 $613.78 | ▲ +3.33% | ▲ +3.73% | $650.08 (+9.44%) |
Jul 23, 2026 10w ago | 8-K | $572.32 $627.55 | ▲ +9.65% | ▲ +6.34% | $650.08 (+13.59%) |
Jun 11, 2026 16w ago | ANALYST-UPGRADE | $469.34 $527.05 | ▲ +12.30% | ▲ +10.52% | $650.08 (+38.51%) |
Jun 11, 2026 16w ago | Institutional Cluster | $475.66 $524.71 | ▲ +10.31% | ▲ +8.42% | $650.08 (+36.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access